Skip to main content
HR 3810 118th Congress House Health Consumer affairs Government information and archives Manufacturing Prescription drugs

Drug Origin Transparency Act of 2023

Introduced: July 11, 2023 See on congress.gov
Sign in to write a letter Sign in to watch
This bill died when the 118th Congress ended
It never became law before the 118th Congress (2023–2024) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jun 9, 2023
Referred to the Subcommittee on Health.
Jun 5, 2023
Referred to the House Committee on Energy and Commerce.
Jun 5, 2023
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Plain-English summary Congressional Research Service

Drug Origin Transparency Act of 2023 

This bill requires drug manufacturers to report on the suppliers of ingredients used in their products.

Specifically, drug manufacturers must report information relating to the supply chain of their products, including the suppliers of active ingredients and the amount of drugs that are manufactured using those ingredients. Drug manufacturers must also include information about the manufacturers of ingredients on the labels of their products.

What's happening now June 9, 2023

Referred to the Subcommittee on Health.

 Related & companion bills 1
  • HR 4697 Related bill Protecting PAHPA Act of 2023
 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 2
 Lobbying activity 1

Registered lobbyists who named this bill in their disclosure filings. Source: federal Lobbying Disclosure Act filings.

  • THORN RUN PARTNERS
    for PROFESSIONAL COMPOUNDING CENTERS OF AMERICA · Texas · 1st Quarter (Jan 1 - Mar 31) 2025
 Cosponsors 4
All 4 Democratic 2
Cárdenas, Tony
· Sep 13, 2023
 D
Peters, Scott H.
California · Jul 25, 2023
 D
Craig, Angie
Minnesota · Jul 11, 2023
Sarbanes, John
· Jul 11, 2023
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 3810: Drug Origin Transparency Act of 2023. 118th Congress. Open America. https://openamerica.io/bill/118-HR-3810/
MLA
"H.R. 3810: Drug Origin Transparency Act of 2023." 118th Congress, 2026, Open America, https://openamerica.io/bill/118-HR-3810/.
Bluebook (legal)
H.R. 3810, 118th Cong. (2026), https://openamerica.io/bill/118-HR-3810/.
Markdown link
[H.R. 3810: Drug Origin Transparency Act of 2023](https://openamerica.io/bill/118-HR-3810/)
Report a problem